Cure.

07/25/2025

🚀 Announcing the Cure Membership
Built for healthcare innovators ready to scale.

Whether you're launching or raising, Cure connects you to the people, tools, and events that move you forward.

🔑 Member Perks:
• Founder & investor network
• Premium video courses
• Events at Cure HQ
• Mentorship

📍 NYC-based? Get access at our Park Ave South campus.
🔥 Founding Member spots are limited—Apply Now. [Link in Bio]

06/03/2025

📍Live from Cure’s Rooftop at

We hosted Power Shift: The Consumer Revolution Rewriting Healthcare’s Rules with our partners Sn**ch Health and — and here’s what we heard:

💡 Consumers want better care, more options, and they’re willing to pay for it, especially if its personalized. But in today’s market, attention is scarce and trust is everything!

🎙 Moderated by our CEO , the panel featured:
👩‍⚕️ – CEO,
💊 – CEO,
💼 Jordan Pascasio – Investor, Next Ventures

05/15/2025

🎤 Live from Cure today!

We’re proud to host ’s first-ever U.S. conference — SiS New York 2025 — bringing together powerhouse voices shaping the future of women’s health.

The opening panel which Cure CEO participated in was a game-changing discussion on closing the gender data gap with Amanda Ducach, and Danika Kelly. Kumar emphasized…

“What doesn’t get measured doesn’t get funded, and what doesn’t get funded doesn’t get solved.” – Seema Kumar

04/09/2025

In an exclusive interview with Cure, co-founders and share how they’re scaling without compromising care and why staying laser-focused on women’s health issues throughout their lifespan has allowed them to never lose focus on the patient.
“Every single woman that we talked to had a story about a bad healthcare experience.” –
Tia’s model is built around changing that. By combining virtual and in-person care, and integrating primary and specialty services, they’re redesigning healthcare that works for women.
Read more at the link in bio! 👆

04/02/2025

This morning, Cure CEO announced as the company’s Chief Content Officer and a key member of the senior leadership team.

Rachel will oversee all content initiatives across platforms, ensuring they are engaging, evidence-based, and aligned with the needs of Cure’s diverse ecosystem of researchers, founders, investors, and policymakers.

“Rachel brings an unmatched blend of editorial excellence, health expertise, and strategic vision that aligns perfectly with Cure’s mission to accelerate health breakthroughs and drive engagement across the health innovation community. Her leadership will be instrumental in shaping powerful narratives and high-impact educational content that inspire innovation, foster collaboration, and provide valuable resources to healthcare entrepreneurs.”
– Seema Kumar, Cure CEO

Please join us in welcoming Rachel to the Cure ecosystem!

03/27/2025

03/24/2025

Happening Now at the Power of X Summit— , President and CEO and Dr. Suzanne Fenske discuss the how women make up 51% of the population and everyone will go through menopause, this no longer a taboo but a huge market opportunity, workforce issue and research imperative.

03/24/2025

The Power of X Summit is underway—spotlighting how investing in women’s health isn’t just a moral imperative, it’s a massive market opportunity.

Cure CEO opened the day, making it clear: scientific innovation fuels economic growth, and women’s health is the most significant untapped opportunity in the biomedical industry.

Then, Carolee Lee Lee, CEO of , drove it home with insights from the latest WHAM Report—laying out a compelling business case for accelerating investment in women’s health to drive economic impact.

Later, Seema Kumar sat down with former FDA Commissioner Dr. Margaret Hamburg for a candid conversation on the challenges facing the biomedical landscape, the chaos at plus the urgent need to close gaps in maternal health and other critically underserved areas in women’s health including and .

03/20/2025

Today in Cure CEO Seema Kumar says “For a successful startup, you need scientific leadership with a breakthrough innovation, commercial leadership that understands the market, and the data to make a compelling business case, too often, these elements exist in isolation from one another.”
Cure. aims to be the connective tissue between these worlds – bridging gaps between startups and investors, young innovators and experienced professionals, researchers and the private sector.”

01/02/2025

TODAY: Cure CEO rang in more than just the New Year with ‘s Director Renee Wegrzyn, her team, and Sprint for Womens Health awardee Daré Bioscience, Inc., they rang ’s first closing bell of 2025 promoting. The ringing of the bell signifies the importance of investing in women’s health with a simple yet powerful message: “Dare to Invest in Women’s Health.”

Here’s to kicking off 2025 with the Power of X and a message of hope that we will one day find cures for what ails women most.

11/22/2024

Breast cancer accounts for one in three new female cancers every year in the United States. While detection and treatments have improved, the quest for more effective and less invasive solutions is far from over.

In a recent conversation on Tuesday Talks, hosted by Cure CEO with , an award-winning journalist and cancer survivor, shared her battle with breast cancer and her efforts to accelerate the development of cancer vaccines through her organization, the . Read more: https://wewillcure.com/insights/oncology/kristen-dahlgrens-journey-to-cancer-vaccine-advocate

10/18/2024

Join us on October 22nd at 12:30pm for next Tuesday Talks with to learn more the and her goal to bring a breast cancer vaccine to market within 5 to 10 years. This is a not to miss episode as breast cancer occurs in 1 out of 8 women. Watch this episode live on our website at www.wewillcure.com or on our page.